Ibere Pharmaceuticals

Ibere Pharmaceuticals is a blank check company whose business purpose is to carry out mergers, share exchanges, asset acquisitions, share purchases, reorganizations, or similar business combinations. According to EablePharma, due to patent expirations between 2020 and 2026, global prescription drug sales are expected to lose approximately $252 billion in total. Therefore, Ibere Pharmaceuticals is targeting a large, addressable market. Our management team has over 100 years of track record in successfully identifying, successfully identifying, and communicating.